Company intelligence
Tempus AI
Tempus AI, Inc. (NASDAQ: TEM) is a technology company leading the adoption of AI to advance precision medicine.
About Tempus AI
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.
Verified activity
Signals from Tempus AI
3 published signals
Research & Knowledge
Tempus AI congratulated the SERENA6 study team for their oncology trials.
Reported by Alan Tan, MD
Research & Knowledge
Tempus AI is developing a living data model that connects biological data to its source, normalizes it, and uses AI to answer new questions as they arrive.
Reported by Sam Seymour
Presence & Recognition
Tempus AI shared thoughts on operationalizing ctDNA in bladder cancer clinical trials at the BCANTT26 BCAN Think Tank in Denver.
Reported by Alan Tan, MD